AlgaeCytes

Kent, United Kingdom Founded: 2010 • Age: 16 yrs
Omega 3 oils and bio-actives are manufactured from freshwater algae.
Annual revenue - Latest available
Total funding $5.7M 2 rounds
Employees 12 Tracked headcount
Investors 3 Known backers
Products 2 Services tracked
Competitors 9 Brand Intelligence

About AlgaeCytes

AlgaeCytes is a company based in United Kingdom founded in 2010. AlgaeCytes has raised $5.73 million across 2 funding rounds from investors including IBG Beteiligungsgesellschaft Sachsen-Anhalt, BMWK and Germany Trade & Invest. The company has 12 employees as of December 31, 2021. AlgaeCytes offers products and services including Omega-3 EPA and Agricultural Biostimulant. AlgaeCytes operates in a competitive market with competitors including Polaris, Solutex, Oceans Omega, Algisys and Zinzino, among others.

  • Headquarter Kent, United Kingdom
  • Employees 12 as on 31 Dec, 2021
  • Sectors
    Healthcare
  • Email
    Locked
  • Phone
    Locked
  • Website
    Locked
  • Social
    Locked
  • Legal Name Algaecytes Limited
  • Date of Incorporation 25 May, 2010
  • Jurisdiction CANTERBURY, KENT
Operational Areas
Healthcare → Nutrition, Wellness & Lifestyle Health Unlock Sub-Sector Unlock Segment
Key Metrics
  • Annual Revenue
    Not available
  • Net Profit
    Not available
  • EBITDA
    Not available
  • Total Equity Funding
    $5.73 M (USD)

    in 2 rounds

  • Latest Funding Round
    $12.6 M (USD), Grant

    Jan 14, 2022

  • Investors
  • Employee Count
    12

    as on Dec 31, 2021

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Products & Services of AlgaeCytes

AlgaeCytes offers a comprehensive portfolio of products and services, including Omega-3 EPA and Agricultural Biostimulant.

Product name locked
Category locked
Primary

Algae-derived Omega-3 for dietary supplements and health products

Product name locked
Category locked
Locked

Enhances crop growth using sustainable algae-based compounds

People of AlgaeCytes

Headcount 10-50
Employee Profiles 2
Employee Profiles
People
Andrew Cosentino
CEO

Unlock access to complete

Teams

Unlock access to complete

Funding Insights of AlgaeCytes

AlgaeCytes has successfully raised a total of $5.73M across 2 strategic funding rounds. The most recent funding activity was a Grant round of $12.6 million completed in January 2022. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

Investors in AlgaeCytes

AlgaeCytes has secured backing from 3 investors, including venture fund and institutional investors. Prominent investors backing the company include IBG Beteiligungsgesellschaft Sachsen-Anhalt, BMWK and Germany Trade & Invest.

All
Venture Fund
Institutional
Investor Description Founded Year Domain Location
-
Locked Locked Locked
-
Locked Locked Locked
Germany Trade & Invest is focused on promoting international business expansion in Germany.
Locked Locked Locked
Premium access

Investor details for AlgaeCytes

Investor domains, locations, round participation, and complete history require an active premium plan.

  • Investor domains
  • Investor locations
  • Funding rounds
  • Participation history

Verified entity values are shown only after access is granted.

Investments & Acquisitions by AlgaeCytes

Investments
Premium access

Investment portfolio details for AlgaeCytes

Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.

  • Portfolio identities
  • Transaction dates
  • Round details
  • Investment values

Verified entity values are shown only after access is granted.

Financial Statements - AlgaeCytes

Premium access

Detailed financials for AlgaeCytes

Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.

  • Historical revenue
  • Profit trends
  • Statement rows
  • Financial ratios

Verified entity values are shown only after access is granted.

Algaecytes Comparisons

AlgaeCytes Primary company
Description
Omega 3 oils and bio-actives are manufactured from freshwate...
Location
United Kingdom
Founded Year
2010
Annual Revenue
Not available
Net Profit
Not available
EBITDA
Not available
Employees
12
As of 2021
Premium access

Peer comparison for AlgaeCytes

Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.

  • Named peers
  • Headcount comparison
  • Funding comparison
  • Operating benchmarks

Verified entity values are shown only after access is granted.

+
Add Comparison
Available on Premium

Competitors of AlgaeCytes

AlgaeCytes operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Polaris, Solutex, Oceans Omega, Algisys and Zinzino, among others.

Company Name Domain Founded year HQ Location Description
Locked Locked Locked
Nutritional functional foods and Omega-3 ingredients are developed.
Locked Locked Locked
Solutex is recognized as a leading manufacturer of omega-3 ingredients.
Locked Locked Locked
Omega-3 concentrates are developed and marketed for functional foods.
Locked Locked Locked
Algal-based EPA omega-3 oils and vegan protein are produced.
Locked Locked Locked
Personalized supplements are manufactured based on omega-6/omega-3 ratio tests.
Premium access

Detailed competitors of AlgaeCytes

Competitor domains, locations, full profiles, and operating metrics require an active premium plan.

  • Domains and locations
  • Full company profiles
  • Operating metrics
  • Competitive positioning

Verified entity values are shown only after access is granted.

Latest news on Algaecytes

Premium access

Complete news archive for AlgaeCytes

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about AlgaeCytes

AlgaeCytes was founded in 2010 and raised its 1st funding round 12 years after it was founded.

AlgaeCytes is headquartered in United Kingdom. It is registered at Kent, United Kingdom.

Naz Bashir is the current CEO of AlgaeCytes.

AlgaeCytes is a funded company, having raised a total of $5.73M across 2 funding rounds to date.

As of Dec 31, 2021, the latest employee count at AlgaeCytes is 12.

AlgaeCytes was founded in 2010 and is based in Kent, United Kingdom. Operations center on the production of omega 3 oils and bio-actives derived from freshwater algae. These products are supplied to the healthcare, personal care, and nutraceuticals sectors. The focus remains on sustainable sourcing and processing for industrial applications in these markets.

AlgaeCytes's top competitors include Zinzino, Algisys and Oceans Omega.

AlgaeCytes offers Omega-3 EPA and Agricultural Biostimulant.

AlgaeCytes has 3 investors. Key investors include IBG Beteiligungsgesellschaft Sachsen-Anhalt, BMWK, and Germany Trade & Invest.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available